Global Heparin Anticoagulant Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 09 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Heparin Anticoagulant market size is expected to reach $ 2307.9 million by 2029, rising at a market growth of 3.1% CAGR during the forecast period (2023-2029).

Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.

North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

This report studies the global Heparin Anticoagulant production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Heparin Anticoagulant, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Heparin Anticoagulant that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Heparin Anticoagulant total production and demand, 2018-2029, (K Units)
Global Heparin Anticoagulant total production value, 2018-2029, (USD Million)
Global Heparin Anticoagulant production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Heparin Anticoagulant consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Heparin Anticoagulant domestic production, consumption, key domestic manufacturers and share
Global Heparin Anticoagulant production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Heparin Anticoagulant production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Heparin Anticoagulant production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Heparin Anticoagulant market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharmacare Holdings, Baxter International, GlaxoSmithKline, Dr. Reddy’s Laboratories, Fresenius Kabi, Leo Pharma, Mylan, Novartis and Pfizer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Heparin Anticoagulant market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Heparin Anticoagulant Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Heparin Anticoagulant Market, Segmentation by Type
Unfractionated Heparin (UF)
Low Molecular Weight Heparin (LMWH)
Ultra-low Molecular Weight Heparin (ULMWH)

Global Heparin Anticoagulant Market, Segmentation by Application
Assisted Living Facilities
Home Healthcare
Hospitals
Nursing Homes and Private Clinics

Companies Profiled:
Aspen Pharmacare Holdings
Baxter International
GlaxoSmithKline
Dr. Reddy’s Laboratories
Fresenius Kabi
Leo Pharma
Mylan
Novartis
Pfizer
Sanofi
Syntex
Teva

Key Questions Answered
1. How big is the global Heparin Anticoagulant market?
2. What is the demand of the global Heparin Anticoagulant market?
3. What is the year over year growth of the global Heparin Anticoagulant market?
4. What is the production and production value of the global Heparin Anticoagulant market?
5. Who are the key producers in the global Heparin Anticoagulant market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Heparin Anticoagulant Introduction
    1.2 World Heparin Anticoagulant Supply & Forecast
        1.2.1 World Heparin Anticoagulant Production Value (2018 & 2022 & 2029)
        1.2.2 World Heparin Anticoagulant Production (2018-2029)
        1.2.3 World Heparin Anticoagulant Pricing Trends (2018-2029)
    1.3 World Heparin Anticoagulant Production by Region (Based on Production Site)
        1.3.1 World Heparin Anticoagulant Production Value by Region (2018-2029)
        1.3.2 World Heparin Anticoagulant Production by Region (2018-2029)
        1.3.3 World Heparin Anticoagulant Average Price by Region (2018-2029)
        1.3.4 North America Heparin Anticoagulant Production (2018-2029)
        1.3.5 Europe Heparin Anticoagulant Production (2018-2029)
        1.3.6 China Heparin Anticoagulant Production (2018-2029)
        1.3.7 Japan Heparin Anticoagulant Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Heparin Anticoagulant Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Heparin Anticoagulant Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Heparin Anticoagulant Demand (2018-2029)
    2.2 World Heparin Anticoagulant Consumption by Region
        2.2.1 World Heparin Anticoagulant Consumption by Region (2018-2023)
        2.2.2 World Heparin Anticoagulant Consumption Forecast by Region (2024-2029)
    2.3 United States Heparin Anticoagulant Consumption (2018-2029)
    2.4 China Heparin Anticoagulant Consumption (2018-2029)
    2.5 Europe Heparin Anticoagulant Consumption (2018-2029)
    2.6 Japan Heparin Anticoagulant Consumption (2018-2029)
    2.7 South Korea Heparin Anticoagulant Consumption (2018-2029)
    2.8 ASEAN Heparin Anticoagulant Consumption (2018-2029)
    2.9 India Heparin Anticoagulant Consumption (2018-2029)

3 World Heparin Anticoagulant Manufacturers Competitive Analysis
    3.1 World Heparin Anticoagulant Production Value by Manufacturer (2018-2023)
    3.2 World Heparin Anticoagulant Production by Manufacturer (2018-2023)
    3.3 World Heparin Anticoagulant Average Price by Manufacturer (2018-2023)
    3.4 Heparin Anticoagulant Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Heparin Anticoagulant Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Heparin Anticoagulant in 2022
        3.5.3 Global Concentration Ratios (CR8) for Heparin Anticoagulant in 2022
    3.6 Heparin Anticoagulant Market: Overall Company Footprint Analysis
        3.6.1 Heparin Anticoagulant Market: Region Footprint
        3.6.2 Heparin Anticoagulant Market: Company Product Type Footprint
        3.6.3 Heparin Anticoagulant Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Heparin Anticoagulant Production Value Comparison
        4.1.1 United States VS China: Heparin Anticoagulant Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Heparin Anticoagulant Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Heparin Anticoagulant Production Comparison
        4.2.1 United States VS China: Heparin Anticoagulant Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Heparin Anticoagulant Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Heparin Anticoagulant Consumption Comparison
        4.3.1 United States VS China: Heparin Anticoagulant Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Heparin Anticoagulant Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Heparin Anticoagulant Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Heparin Anticoagulant Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Heparin Anticoagulant Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Heparin Anticoagulant Production (2018-2023)
    4.5 China Based Heparin Anticoagulant Manufacturers and Market Share
        4.5.1 China Based Heparin Anticoagulant Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Heparin Anticoagulant Production Value (2018-2023)
        4.5.3 China Based Manufacturers Heparin Anticoagulant Production (2018-2023)
    4.6 Rest of World Based Heparin Anticoagulant Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Heparin Anticoagulant Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Heparin Anticoagulant Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Heparin Anticoagulant Production (2018-2023)

5 Market Analysis by Type
    5.1 World Heparin Anticoagulant Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Unfractionated Heparin (UF)
        5.2.2 Low Molecular Weight Heparin (LMWH)
        5.2.3 Ultra-low Molecular Weight Heparin (ULMWH)
    5.3 Market Segment by Type
        5.3.1 World Heparin Anticoagulant Production by Type (2018-2029)
        5.3.2 World Heparin Anticoagulant Production Value by Type (2018-2029)
        5.3.3 World Heparin Anticoagulant Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Heparin Anticoagulant Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Assisted Living Facilities
        6.2.2 Home Healthcare
        6.2.3 Hospitals
        6.2.4 Nursing Homes and Private Clinics
    6.3 Market Segment by Application
        6.3.1 World Heparin Anticoagulant Production by Application (2018-2029)
        6.3.2 World Heparin Anticoagulant Production Value by Application (2018-2029)
        6.3.3 World Heparin Anticoagulant Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Aspen Pharmacare Holdings
        7.1.1 Aspen Pharmacare Holdings Details
        7.1.2 Aspen Pharmacare Holdings Major Business
        7.1.3 Aspen Pharmacare Holdings Heparin Anticoagulant Product and Services
        7.1.4 Aspen Pharmacare Holdings Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Aspen Pharmacare Holdings Recent Developments/Updates
        7.1.6 Aspen Pharmacare Holdings Competitive Strengths & Weaknesses
    7.2 Baxter International
        7.2.1 Baxter International Details
        7.2.2 Baxter International Major Business
        7.2.3 Baxter International Heparin Anticoagulant Product and Services
        7.2.4 Baxter International Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Baxter International Recent Developments/Updates
        7.2.6 Baxter International Competitive Strengths & Weaknesses
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Details
        7.3.2 GlaxoSmithKline Major Business
        7.3.3 GlaxoSmithKline Heparin Anticoagulant Product and Services
        7.3.4 GlaxoSmithKline Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GlaxoSmithKline Recent Developments/Updates
        7.3.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.4 Dr. Reddy’s Laboratories
        7.4.1 Dr. Reddy’s Laboratories Details
        7.4.2 Dr. Reddy’s Laboratories Major Business
        7.4.3 Dr. Reddy’s Laboratories Heparin Anticoagulant Product and Services
        7.4.4 Dr. Reddy’s Laboratories Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Dr. Reddy’s Laboratories Recent Developments/Updates
        7.4.6 Dr. Reddy’s Laboratories Competitive Strengths & Weaknesses
    7.5 Fresenius Kabi
        7.5.1 Fresenius Kabi Details
        7.5.2 Fresenius Kabi Major Business
        7.5.3 Fresenius Kabi Heparin Anticoagulant Product and Services
        7.5.4 Fresenius Kabi Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Fresenius Kabi Recent Developments/Updates
        7.5.6 Fresenius Kabi Competitive Strengths & Weaknesses
    7.6 Leo Pharma
        7.6.1 Leo Pharma Details
        7.6.2 Leo Pharma Major Business
        7.6.3 Leo Pharma Heparin Anticoagulant Product and Services
        7.6.4 Leo Pharma Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Leo Pharma Recent Developments/Updates
        7.6.6 Leo Pharma Competitive Strengths & Weaknesses
    7.7 Mylan
        7.7.1 Mylan Details
        7.7.2 Mylan Major Business
        7.7.3 Mylan Heparin Anticoagulant Product and Services
        7.7.4 Mylan Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Mylan Recent Developments/Updates
        7.7.6 Mylan Competitive Strengths & Weaknesses
    7.8 Novartis
        7.8.1 Novartis Details
        7.8.2 Novartis Major Business
        7.8.3 Novartis Heparin Anticoagulant Product and Services
        7.8.4 Novartis Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Novartis Recent Developments/Updates
        7.8.6 Novartis Competitive Strengths & Weaknesses
    7.9 Pfizer
        7.9.1 Pfizer Details
        7.9.2 Pfizer Major Business
        7.9.3 Pfizer Heparin Anticoagulant Product and Services
        7.9.4 Pfizer Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Pfizer Recent Developments/Updates
        7.9.6 Pfizer Competitive Strengths & Weaknesses
    7.10 Sanofi
        7.10.1 Sanofi Details
        7.10.2 Sanofi Major Business
        7.10.3 Sanofi Heparin Anticoagulant Product and Services
        7.10.4 Sanofi Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Sanofi Recent Developments/Updates
        7.10.6 Sanofi Competitive Strengths & Weaknesses
    7.11 Syntex
        7.11.1 Syntex Details
        7.11.2 Syntex Major Business
        7.11.3 Syntex Heparin Anticoagulant Product and Services
        7.11.4 Syntex Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Syntex Recent Developments/Updates
        7.11.6 Syntex Competitive Strengths & Weaknesses
    7.12 Teva
        7.12.1 Teva Details
        7.12.2 Teva Major Business
        7.12.3 Teva Heparin Anticoagulant Product and Services
        7.12.4 Teva Heparin Anticoagulant Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Teva Recent Developments/Updates
        7.12.6 Teva Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Heparin Anticoagulant Industry Chain
    8.2 Heparin Anticoagulant Upstream Analysis
        8.2.1 Heparin Anticoagulant Core Raw Materials
        8.2.2 Main Manufacturers of Heparin Anticoagulant Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Heparin Anticoagulant Production Mode
    8.6 Heparin Anticoagulant Procurement Model
    8.7 Heparin Anticoagulant Industry Sales Model and Sales Channels
        8.7.1 Heparin Anticoagulant Sales Model
        8.7.2 Heparin Anticoagulant Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Heparin Anticoagulant Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Heparin Anticoagulant Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Heparin Anticoagulant Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Heparin Anticoagulant Production Value Market Share by Region (2018-2023)
    Table 5. World Heparin Anticoagulant Production Value Market Share by Region (2024-2029)
    Table 6. World Heparin Anticoagulant Production by Region (2018-2023) & (K Units)
    Table 7. World Heparin Anticoagulant Production by Region (2024-2029) & (K Units)
    Table 8. World Heparin Anticoagulant Production Market Share by Region (2018-2023)
    Table 9. World Heparin Anticoagulant Production Market Share by Region (2024-2029)
    Table 10. World Heparin Anticoagulant Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Heparin Anticoagulant Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Heparin Anticoagulant Major Market Trends
    Table 13. World Heparin Anticoagulant Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Heparin Anticoagulant Consumption by Region (2018-2023) & (K Units)
    Table 15. World Heparin Anticoagulant Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Heparin Anticoagulant Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Heparin Anticoagulant Producers in 2022
    Table 18. World Heparin Anticoagulant Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Heparin Anticoagulant Producers in 2022
    Table 20. World Heparin Anticoagulant Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Heparin Anticoagulant Company Evaluation Quadrant
    Table 22. World Heparin Anticoagulant Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Heparin Anticoagulant Production Site of Key Manufacturer
    Table 24. Heparin Anticoagulant Market: Company Product Type Footprint
    Table 25. Heparin Anticoagulant Market: Company Product Application Footprint
    Table 26. Heparin Anticoagulant Competitive Factors
    Table 27. Heparin Anticoagulant New Entrant and Capacity Expansion Plans
    Table 28. Heparin Anticoagulant Mergers & Acquisitions Activity
    Table 29. United States VS China Heparin Anticoagulant Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Heparin Anticoagulant Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Heparin Anticoagulant Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Heparin Anticoagulant Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Heparin Anticoagulant Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Heparin Anticoagulant Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Heparin Anticoagulant Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Heparin Anticoagulant Production Market Share (2018-2023)
    Table 37. China Based Heparin Anticoagulant Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Heparin Anticoagulant Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Heparin Anticoagulant Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Heparin Anticoagulant Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Heparin Anticoagulant Production Market Share (2018-2023)
    Table 42. Rest of World Based Heparin Anticoagulant Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Heparin Anticoagulant Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Heparin Anticoagulant Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Heparin Anticoagulant Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Heparin Anticoagulant Production Market Share (2018-2023)
    Table 47. World Heparin Anticoagulant Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Heparin Anticoagulant Production by Type (2018-2023) & (K Units)
    Table 49. World Heparin Anticoagulant Production by Type (2024-2029) & (K Units)
    Table 50. World Heparin Anticoagulant Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Heparin Anticoagulant Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Heparin Anticoagulant Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Heparin Anticoagulant Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Heparin Anticoagulant Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Heparin Anticoagulant Production by Application (2018-2023) & (K Units)
    Table 56. World Heparin Anticoagulant Production by Application (2024-2029) & (K Units)
    Table 57. World Heparin Anticoagulant Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Heparin Anticoagulant Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Heparin Anticoagulant Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Heparin Anticoagulant Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Aspen Pharmacare Holdings Basic Information, Manufacturing Base and Competitors
    Table 62. Aspen Pharmacare Holdings Major Business
    Table 63. Aspen Pharmacare Holdings Heparin Anticoagulant Product and Services
    Table 64. Aspen Pharmacare Holdings Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Aspen Pharmacare Holdings Recent Developments/Updates
    Table 66. Aspen Pharmacare Holdings Competitive Strengths & Weaknesses
    Table 67. Baxter International Basic Information, Manufacturing Base and Competitors
    Table 68. Baxter International Major Business
    Table 69. Baxter International Heparin Anticoagulant Product and Services
    Table 70. Baxter International Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Baxter International Recent Developments/Updates
    Table 72. Baxter International Competitive Strengths & Weaknesses
    Table 73. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 74. GlaxoSmithKline Major Business
    Table 75. GlaxoSmithKline Heparin Anticoagulant Product and Services
    Table 76. GlaxoSmithKline Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GlaxoSmithKline Recent Developments/Updates
    Table 78. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 79. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
    Table 80. Dr. Reddy’s Laboratories Major Business
    Table 81. Dr. Reddy’s Laboratories Heparin Anticoagulant Product and Services
    Table 82. Dr. Reddy’s Laboratories Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Dr. Reddy’s Laboratories Recent Developments/Updates
    Table 84. Dr. Reddy’s Laboratories Competitive Strengths & Weaknesses
    Table 85. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
    Table 86. Fresenius Kabi Major Business
    Table 87. Fresenius Kabi Heparin Anticoagulant Product and Services
    Table 88. Fresenius Kabi Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Fresenius Kabi Recent Developments/Updates
    Table 90. Fresenius Kabi Competitive Strengths & Weaknesses
    Table 91. Leo Pharma Basic Information, Manufacturing Base and Competitors
    Table 92. Leo Pharma Major Business
    Table 93. Leo Pharma Heparin Anticoagulant Product and Services
    Table 94. Leo Pharma Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Leo Pharma Recent Developments/Updates
    Table 96. Leo Pharma Competitive Strengths & Weaknesses
    Table 97. Mylan Basic Information, Manufacturing Base and Competitors
    Table 98. Mylan Major Business
    Table 99. Mylan Heparin Anticoagulant Product and Services
    Table 100. Mylan Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Mylan Recent Developments/Updates
    Table 102. Mylan Competitive Strengths & Weaknesses
    Table 103. Novartis Basic Information, Manufacturing Base and Competitors
    Table 104. Novartis Major Business
    Table 105. Novartis Heparin Anticoagulant Product and Services
    Table 106. Novartis Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Novartis Recent Developments/Updates
    Table 108. Novartis Competitive Strengths & Weaknesses
    Table 109. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 110. Pfizer Major Business
    Table 111. Pfizer Heparin Anticoagulant Product and Services
    Table 112. Pfizer Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Pfizer Recent Developments/Updates
    Table 114. Pfizer Competitive Strengths & Weaknesses
    Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 116. Sanofi Major Business
    Table 117. Sanofi Heparin Anticoagulant Product and Services
    Table 118. Sanofi Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Sanofi Recent Developments/Updates
    Table 120. Sanofi Competitive Strengths & Weaknesses
    Table 121. Syntex Basic Information, Manufacturing Base and Competitors
    Table 122. Syntex Major Business
    Table 123. Syntex Heparin Anticoagulant Product and Services
    Table 124. Syntex Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Syntex Recent Developments/Updates
    Table 126. Teva Basic Information, Manufacturing Base and Competitors
    Table 127. Teva Major Business
    Table 128. Teva Heparin Anticoagulant Product and Services
    Table 129. Teva Heparin Anticoagulant Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Heparin Anticoagulant Upstream (Raw Materials)
    Table 131. Heparin Anticoagulant Typical Customers
    Table 132. Heparin Anticoagulant Typical Distributors
List of Figure
    Figure 1. Heparin Anticoagulant Picture
    Figure 2. World Heparin Anticoagulant Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Heparin Anticoagulant Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Heparin Anticoagulant Production (2018-2029) & (K Units)
    Figure 5. World Heparin Anticoagulant Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Heparin Anticoagulant Production Value Market Share by Region (2018-2029)
    Figure 7. World Heparin Anticoagulant Production Market Share by Region (2018-2029)
    Figure 8. North America Heparin Anticoagulant Production (2018-2029) & (K Units)
    Figure 9. Europe Heparin Anticoagulant Production (2018-2029) & (K Units)
    Figure 10. China Heparin Anticoagulant Production (2018-2029) & (K Units)
    Figure 11. Japan Heparin Anticoagulant Production (2018-2029) & (K Units)
    Figure 12. Heparin Anticoagulant Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Heparin Anticoagulant Consumption (2018-2029) & (K Units)
    Figure 15. World Heparin Anticoagulant Consumption Market Share by Region (2018-2029)
    Figure 16. United States Heparin Anticoagulant Consumption (2018-2029) & (K Units)
    Figure 17. China Heparin Anticoagulant Consumption (2018-2029) & (K Units)
    Figure 18. Europe Heparin Anticoagulant Consumption (2018-2029) & (K Units)
    Figure 19. Japan Heparin Anticoagulant Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Heparin Anticoagulant Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Heparin Anticoagulant Consumption (2018-2029) & (K Units)
    Figure 22. India Heparin Anticoagulant Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Heparin Anticoagulant by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Heparin Anticoagulant Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Heparin Anticoagulant Markets in 2022
    Figure 26. United States VS China: Heparin Anticoagulant Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Heparin Anticoagulant Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Heparin Anticoagulant Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Heparin Anticoagulant Production Market Share 2022
    Figure 30. China Based Manufacturers Heparin Anticoagulant Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Heparin Anticoagulant Production Market Share 2022
    Figure 32. World Heparin Anticoagulant Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Heparin Anticoagulant Production Value Market Share by Type in 2022
    Figure 34. Unfractionated Heparin (UF)
    Figure 35. Low Molecular Weight Heparin (LMWH)
    Figure 36. Ultra-low Molecular Weight Heparin (ULMWH)
    Figure 37. World Heparin Anticoagulant Production Market Share by Type (2018-2029)
    Figure 38. World Heparin Anticoagulant Production Value Market Share by Type (2018-2029)
    Figure 39. World Heparin Anticoagulant Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Heparin Anticoagulant Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Heparin Anticoagulant Production Value Market Share by Application in 2022
    Figure 42. Assisted Living Facilities
    Figure 43. Home Healthcare
    Figure 44. Hospitals
    Figure 45. Nursing Homes and Private Clinics
    Figure 46. World Heparin Anticoagulant Production Market Share by Application (2018-2029)
    Figure 47. World Heparin Anticoagulant Production Value Market Share by Application (2018-2029)
    Figure 48. World Heparin Anticoagulant Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Heparin Anticoagulant Industry Chain
    Figure 50. Heparin Anticoagulant Procurement Model
    Figure 51. Heparin Anticoagulant Sales Model
    Figure 52. Heparin Anticoagulant Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Heparin Anticoagulant Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Heparin Anticoagulant Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 02 Feb 2021

date Pharma & Healthcare

The Heparin Anticoagulant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Heparin Anticoagulant Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Heparin Anticoagulant Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 07 Jan 2022

date Pharma & Healthcare

Global Heparin Anticoagulant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Heparin Anticoagulant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 02 Jan 2023

date Pharma & Healthcare

Global Heparin Anticoagulant Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Heparin Anticoagulant Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Heparin Anticoagulant market size was valued at USD 1868.6 million in 2023 and is forecast to a readjusted size of USD 2307.9 million by 2030 with a CAGR of 3.1% during review period.

Product Tags

heparin anticoagulant

Heparin Anticoagulant Drugs

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>